About Spinal Modulation

Addressing a Recognized Need
According to the 2002 Health Assessment on the Prevalence of Chronic Pain, severe chronic pain, as defined by the International Association for the Study of Pain, is prevalent in 10 to 13% of the adult population. Limited treatment options exist for these patients and the burden to the healthcare system is unsustainable.

The Spinal Modulation Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown clinically significant results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.

By stimulating the DRG, therapy can be adjusted to cover either broad or specific areas of pain throughout the torso and legs, while limiting uncomfortable postural effects typically experienced with other spinal cord stimulators.

Developed with World-Renowned Physicians
Through careful observation of patient needs, engagement of world-renowned physicians, and recruitment of top medical-device-industry talent, Spinal Modulation has developed:

• An innovative neuromodulation therapy
• A product expected to address shortcomings of current chronic pain management products
• A way to improve the lives of many patients living with unmanageable pain

By stimulating the dorsal root ganglion, Spinal Modulation has taken a new approach to pain management.

Founded by Experts and Led by Experience
Spinal Modulation was founded in 2004 and the intellectual property and technology platform were developed at Stanford University and InCube Labs. Today the company is:

• Led by seasoned executives
• Supported by a talented workforce
• Guided by world-renowned physicians
• Built on sound medical science
• Funded by top tier investors
• With operations in both the United States and internationally (Belgium).